Guselkumab in Crohn's disease: the IL-23 race continues. Fumery M, Buisson A. Lancet Gastroenterol Hepatol 2023 Dec 14:S2468-1253(23)00356.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fumery M, Buisson A. Guselkumab in Crohn's disease: the IL-23 race continues. Lancet Gastroenterol Hepatol 2023 Dec 14:S2468-1253(23)00356.
PMID: 38104570